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Purpose: Because dipyridamole thall ium (DT) scanning is a useful predictor of  perioper- 
ative cardiac events, a positive result o f  a DT scan is frequently the basis for performing 
more invasive cardiac evaluation and for consideration for performing coronary revascu- 
larization procedures before performing peripheral vascular surgery. The rationale for 
this approach has been that the treatment of  anatomically significant coronary artery 
disease would lower the risk of  performing a subsequent vascular operation. However, 
the benefit of  performing aggressive diagnostic and therapeutic ardiac procedures in 
such patients remains unproved. To examine this issue, data from patients who under- 
went coronary angiography because of  thall ium redistr ibution were compared with data 
from matched control subjects who underwent peripheral vascular operations without 
further cardiac evaluation. 
Methods: The medical records of  70 consecutive patients who underwent coronary angiog- 
raphy because of  the presence of  two or more segments of  redistr ibution on DT scan were 
reviewed and compared with 70 other patients matched with respect o age, gender, 
peripheral vascular operation, and number of  segments of  redistr ibution on DT scan who 
did not  undergo additional cardiac evaluation. 
Results: DT scans were performed on 934 preoperative peripheral vascular surgery 
patients to help in the assessment of operative risk. Ischemic responses, defined as two or 
more segments of  redistribution, were observed in 297. Of  these, 70 underwent cardiac 
catheterization and 25 underwent coronary revascularization procedures. Adverse out- 
comes affected 46% of  the coronary angiography group and 44% of the control group (p = 
NS). Patients who underwent coronary angiography and were considered for myocardial 
revascularization had fewer cardiac events with a subsequent vascular operation than did 
the control subjects. However, any possible benefit from invasive cardiac evaluation was 
offset by the three deaths and two myocardial infarctions (MIs) that complicated the 
cardiac evaluation. There was no significant difference between the angiography group 
and the matched control subjects with respect to perioperative nonfatal MI  (13% vs 9%), 
fatal MI  (4% vs 3%), late nonfatal MI  (16% vs 19%), or late cardiac death (10% vs 13%). In 
long-term follow-up, MIs occurred later in patients who underwent coronary angiogra- 
play than the control subjects (p = 0.049), but this difference was not  associated with an 
improvement in the overall survival rate. 
Conclusions: The risks of  extended cardiac evaluation and treatment did not  produce any 
improvement in either the perioperative or the long-term survival rate. For most vascular 
surgery patients who have a positive result of  a DT scan, coronary angiography does not 
provide any additional useful information. (J Vasc Surg 1997;25:975-83.) 
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Table I. Peripheral vascular operations in 
coronary angiography and control groups 
Coronary 
Vascular operation angiography Control 
Abdominal aortic aneurysm 20 22 
Aortobifemoral bypass 13 14 
Extraanatomic bypass 5 5 
Carotid endarterectomy 9 9 
Inffainguinal bypass 14 14 
Amputation 3 3 
Died before vascular operation 3 0 
Vascular surgery canceled 3 3 
Coronary artery disease (CAD) is the most im- 
portant cause of morbidity and death after peripheral 
arterial surgery. Efforts to lower the risk of complica- 
tions from CAD have been largely directed toward 
definition of the anatomic extent of the disease, ei- 
ther through noninvasive testing, such as dipyridam- 
ole thallium (DT) scanning, or coronary angiogra- 
phy. I f  severe CAD is suspected on clinical grounds 
or on the basis of more objective testing, then it has 
been assumed that a preliminary procedure to correct 
the coronary insufficiency would make a subsequent 
vascular surgical operation safer. Although this ap- 
proach is logical, its benefit remains unproved. To 
examine this issue, we retrospectively compared the 
outcomes of 70 patients who underwent cardiac 
catheterization a d selective myocardial revascular- 
ization procedures prompted by thallium redistribu- 
tion on DT scan with the outcomes of 70 matched 
control subjects who underwent a peripheral vascular 
operation without further cardiac assessment. 
METHODS 
Routine preoperative screening DT scans were 
performed on 934 patients in anticipation of elective 
aortic, carotid, or infrainguinal arterial operation at 
the University of Massachusetts Medical Center be- 
tween January 1, 1984, and December 31, 1995. 
Significant myocardial ischemia, which was defined 
as two or more segments of redistribution on the DT 
scan, ~ was observed in 297 of the patients. A planar 
imaging technique was used with a nine-segment 
model to interpret and report he DT scan images. 2,a 
A consultation from a cardiologist was obtained 
for all patients who had significant abnormalities on 
DT scan. As a result of these evaluations, 70 patients 
underwent diagnostic oronary angiography. These 
patients were matched with control subjects from the 
remaining 227 patients with multiple areas of redis- 
tribution on DT scan who underwent the same pe- 
ripheral vascular operation without undergoing pre- 
liminary cardiac cathctcrization. Patients were 
matched according to the following equally 
weighted criteria: (1) age + 5 years; (2) gender; (3) 
number of segments of redistribution on DT scan; 
(4) peripheral vascular diagnosis; and (5) planned 
peripheral vascular operation. The matching was per- 
formed by an investigator who was not involved in 
the clinical care of the patients and was therefore 
blinded as to the clinical events and outcomes. For 
63 of 70 patients, all matching criteria were met. 
There were seven patients from the cardiac atheter- 
ization group with four areas of redistribution who 
were matched with noncatheterized patients who 
had three segments of redistribution to maintain 
uniformity with respect o age, gender, anatomical 
distribution of vascular disease, and operation. These 
seven patients included five women with carotid ar- 
tery stenosis, one woman with infrainguinal disease, 
and one man with an abdominal aortic aneurysm. 
Patients in the coronary angiography group who 
died after evaluation and treatment of CAD were 
matched with control subjects who underwent the 
intended peripheral vascular procedure (Table I). 
Unmatched patients were excluded from further 
analysis. Three patients from each group underwent 
no peripheral vascular operation. In one patient from 
each group, the surgeon recommended that no op- 
eration be performed because of the extent of the 
underlying cardiac disease. The two other patients in 
each group refused the recommended operation. 
Data were obtained by review of hospital records, 
physician's office notes, and outpatient clinic reports. 
Endpoints for the study were fatal and nonfatal myo- 
cardial infarction (MI), and fatal and nonfatal non- 
cardiac complications related to the treatment of 
coronary or peripheral vascular disease. MI was de- 
fined as an increase in the creatine phosphokinase 
(CPK-MB) index of 5% or greater or a new Q-wave 1 
mm or greater on an electrocardiogram. Adverse 
outcomes were classified as perioperative or late. The 
perioperative p riod was defined as the time from the 
date of preoperative DT scan to 30 days after the final 
operation. Late events occurred more than 30 days 
after surgery. Information concerning DT scan, car- 
diac catheterization, coronary artery bypass grafting 
( CAB G), percutaneous transluminal coronary anglo -
plasty (PTCA), and peripheral vascular operation 
were obtained from the appropriate procedure re- 
ports. Patients who had not been seen for follow-up 
by their physician within 60 days of the end of the 
project were interviewed by telephone for follow-up 
information. 
Mthough the decision to perform a preoperative 
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Table II. Associated medical conditions 
Associated medical Catheterized Control 
condition group group p 
Stable angina 32 (46%) 19 (27%) 0.049* 
Hypertension 51 (73%) 45 (64%) NS* 
Tobacco use 65 (93%) " 53 (76%) NS* 
Diabetes 22 (31%) 19 (27%) NS* 
Previous MI 28 (40%) 28 (40%) NS* 
Congestive heart failure 17 (24%) 9 (13%) NS* 
Previous coronary bypass 10 (14%) 14 (20%) NS* 
Previous PTCA 2 (3%) 1 (1%) NS* 
Chronic obstructive lung 5 (7%) 7 (10%) NS* 
disease 
Renal failure 5 (7%) 7 (10%) NS* 
Eagle's core 4 1.74 -+ 1.43 1.43 -+ 1.53 NS]- 
Detsky's cores s 9.50 +- 9.05 7.86 -+ 0.35 NS]- 
*McNemar's test; ]-paired t test. 
DT scan was made by the attending vascular sur- 
geon, the decision to proceed with coronary angiog- 
raphy rested primarily with the consulting cardiolo- 
gist. The large population of vascular patients who 
underwent a preoperative screening DT scan, com- 
bined with differences in the diagnostic philosophy of 
cardiologists, provided an opportunity to compare 
the outcomes of patients who had similar risk pro- 
files, some of whom underwent coronary angiogra- 
phy while others did not. 
McNemar's test was used to compare dichoto- 
mous variables in the paired patients, and a paired t 
test was applied to evaluate differences in continuous 
variables between the two groups. One-way analysis 
of variance was applied to examine the relationship 
between the number of segments of redistribution 
on DT scan and the number of critical stenoses on 
coronary angiograms. Kaplan-Meier survival analysis 
was used to compare the rates of MI, cardiac death, 
and overall death on members of the two groups. 
The log-rank test and Wilcoxon's rank-sum test were 
applied to determine the statistical significance be- 
tween differences in MI-free survival rate, survival 
rate with respect o cardiac events, and overall sur- 
vival rate. 
RESULTS 
There were no demographic differences found 
between the two groups with respect o the fre- 
quency of hypertension, diabetes, previous MI, 
chronic obstructive lung disease, renal insufficiency, 
and congestive heart failure (Table II). None of the 
patients from either group had unstable angina. Pa- 
tients who underwent coronary angiography were 
more likely to have stable angina (p = 0.049) or a 
history of smoking (p = 0.019). A history of prior 
CABG tended to be more frequent in the control 
Table I l L  Comparison of DT scan and 
coronary angiography 
Segments of Average number of 
redistribution vessels >70% 
0-1 
2 2.1 _+ 1.24 
3 2.2 _+ 1.35 
4 2.5 + 1.30 
5 3.0 + 0.71 
6 3.0 -+ 0.00 
F statistic, 1.30 with 3 and 66 degrees of freedom, p = NS. 
group, but this difference did not reach statistical signif- 
icance (p = 0.052). Patients from both groups were 
classified according to the cardiac risk criteria of Eagle 
et al.* and Detsky et al.5 In both cases, no significant 
differences were noted between these two groups with 
respect to the two clinical risk scoring systems. 
The following criteria were evaluated by univari- 
ate analysis for their ability to predict a perioperative 
MI: age, gender, vascular diagnosis, vascular opera- 
tion, the method of treatment of CAD, the number 
of segments of  redistribution on DT scan, ejection 
fraction, history of CABG, history of pulmonary dis- 
ease, the criteria of Eagle et al., and the cardiac risk 
analyses of Detsky et al. None was found to be 
predictive for a perioperative MI. 
Angiographic evidence of CAD was present in all 
70 patients who underwent coronary angiography 
(Table III). Ninety percent had one or more coro- 
nary lesions that resulted in a >70% reduction in 
lumen diameter. In general, patients who had more 
areas of redistribution on DT scan were more likely 
to have a larger number of critical lesions identified 
by coronary angiography (p = NS). The two patients 
who had six areas of redistribution on DT scan had 
critical stenoses in all three coronary distributions. 
Of  those patients who underwent coronary an- 
giography, 24 subsequently underwent coronary ar- 
tery bypass urgery and one underwent PTCA. Cor- 
onary revascularization was not performed in the 
other 45 patients. Of  those 45 patients, there were 
no critical stenoses or there was a patent bypass graft 
supplying the affected region in 16. Critical coronary 
stenoses were present in 23 other patients, but the 
area of myocardium at risk was sufficiently small that 
coronary revascularization could not be justified. In 
five patients a revascularization procedure was tech- 
nically not feasible as a result of the diffuse nature of 
the CAD. The last patient refused evaluation by a 
cardiothoracic surgeon. Based on the finding of re- 
distribution on DT scan, 33 of the 45 patients who 
did not undergo myocardial revascularization had a 
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Table IV. Adverse outcomes 
Coronary 
angiography Control 
Outcome group group 
Perioperative events 
Angiography and revascularization 
Nonfatal MI 2 (3%) - -  
Fatal MI 2 (3%) - -  
Noncardiac morbidity 3 (4%) - -  
Noncardiac death 1 (1%) - -  
Total death 3 (4%) - -  
Peripheral vascular operation 
Nonfatal MI 8 (11%) 13 (19%) 
Fatal MI i (1%) 2 (3%) 
Noncardiac morbidity 6 (9%) 4 (6%) 
Noncardiac death 0 (0%) 0 (0%) 
Total death 1 (1%) 2 (3%) 
Late events 
Nonfatal MI 11 (16%) 13 (19%) 
Fatal MI 7 (10%) 9 (13%) 
Noncardiac death 5 (7%) 8 (11%) 
Total death 12 (17%) 17 (24%) 
Total events 
Nonfatal MI 21 (30%) 26 (37%) 
Fatal MI 10 (14%) 11 (16%) 
Noncardiac morbidity 9 (13%) 4 (6%) 
Noncardiac death 6 (9%) 8 (11%) 
Total death 116 (23%) 19 (27%) 
change in the medical management of their CAD. 
These changes included the addition of nitrates, cal- 
cium channel, or [~-blocking medications. Of the two 
remaining patients, one with aortoiliac disease un- 
derwent placement of an extraanatomic bypass graft 
and the other with claudication was treated conserva- 
tively without operation. 
Patients who underwent coronary angiography 
and selective revascularization procedures tended to 
have fewer MIs during the subsequent vascular pro- 
cedure: there were nine MIs, including one that was 
fatal in the catheterization group, compared with 15 
MIs and two fatalities in the control group. There 
were four MIs, including two that were fatal, and one 
death from a ruptured aortic abdominal aneurysm 
that complicated coronary angiography and myocar- 
dial revascularization procedures. Hence, there was 
no overall improvement that resulted from extended 
cardiac evaluation in the incidence of cardiac events 
(Table IV). There was also no significant difference in 
the incidence of late fatal and nonfatal MI or noncar- 
diac death after a mean follow-up interval of 4.3 years 
(median, 4.0 years) in the coronary angiography 
group (range, 14 days to 11.7 years) and 3.6 years 
(median, 3.2 years) in the control group (range, 9 
days to 12.2 years). Overall, 32 patients (46%) who 
underwent coronary angiography had a cardiac or 
noncardiac event in the postoperative or follow-up 
period, compared with 31 (44%) in the control 
group. 
Life table analysis was applied to compare time to 
first cardiac event (Fig. 1), cardiac mortality data 
(Fig. 2), and cumulative mortality data (Fig. 3). 
Patients from the cardiac atheterization group had a 
longer MI-free survival rate (p = 0.049). No differ- 
ence was noted, however, between the groups with 
respect o overall survival rate or survival rate from 
nonfatal cardiac events. 
DISCUSSION 
DT scintigraphy is a highly sensitive method used 
to identify patients at risk for perioperative and late 
cardiac events) ,68 The therapeutic implications, 
however, of ischemic changes on DT scanning in 
peripheral vascular patients are not clear. Should pa- 
tients with thallium redistribution undergo cardiac 
catheterization and, if hemodynamically important 
lesions are found, coronary revascularization proce- 
dures before peripheral vascular surgery? Or should 
the risks of further cardiac evaluation and aortocoro- 
nary surgery be avoided? In deciding between these 
two alternatives, the added morbidity and mortality 
rates of cardiac atheterization a d myocardial revas- 
cularization procedures and the delay in treatment of 
the peripheral vascular disease must be balanced 
against any improvement in perioperative and late 
survival rates. 
Data from the present study show that those 
patients who underwent preliminary coronary an- 
giography and myocardial revascularization proce- 
dures had fewer fatal and nonfatal MIs during a 
subsequent vascular operation (p = NS). However, 
this apparent benefit was offset by the morbidity that 
was associated with the extended evaluation and 
treatment. Although the number of patients who 
underwent preliminary aortocoronary b pass urgery 
was small, two of the 24 patients had a fatal MI after 
CABG, and one other died of  a ruptured AAA after 
coronary angiography (12.5%). Data from other 
studies have also exhibited a higher morbidity rate 
for coronary operations in patients who have symp- 
tomatic peripheral vascular disease than for individu- 
als who do not have vascular disease. In a frequently 
quoted study from the Cleveland Clinic of 1000 
consecutive patients who underwent coronary an- 
giography before vascular surgery, the operative 
mortality rate for coronary bypass urgery was 5.0%, 
at a time when elective procedures were performed 
with a mortality rate of only 1.2% for nonvascular 
patients. 9 In a more recent series from the Mayo 
Clinic, 1° the mortality rate of aortocoronary bypass 
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Fig. 1. Patients who underwent coronary angiography and selective myocardial revasculariza- 
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Fig. 2. Performing coronary angiography and selective coronary revascularization procedures 
did not reduce the incidence of fatal MIs occurring during long-term follow-up (p = NS). 
surgery for patients 80 years and older was increased 
from 4% without peripheral vascular disease to 16% 
when vascular disease was present. It would therefore 
appear that the presence of symptomatic peripheral 
vascular disease is an important risk factor that in- 
creases the morbidity rate of aortocoronary bypass 
surgery when compared w i th  patients who have 
symptomatic CAD alone. The increased morbidity 
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Fig. 3. Performing coronary angiography and selective coronary revascularization procedures 
did not alter the incidence of death that resulted from all causes during long-term follow-up 
(p = NS). 
rate of CABG will offset any potential reduction in 
the overall perioperative mortality rate associated 
with the primary vascular surgical procedure. 
There are no prospective randomized studies of 
different reatment options for vascular surgical pa- 
tients who have associated CAD with which to com- 
pare the data from the present study. However, Ma- 
son et al?l performed a meta-aualysis of published 
outcome data to compare three treatment strategies 
in peripheral vascular surgery patients who had thal- 
lium redistribution on a preoperative DT scan. The 
first option in their analysis was to perform the vas- 
cular surgical procedure without performing further 
cardiac evaluation. The second alternative was car- 
diac catheterization a d selective coronary revascu- 
larization with cancellation of vascular surgery in 
those patients who had inoperable CAD. The final 
option was sequential cardiac atheterization a d se- 
lective coronary revascularization followed by the 
planned vascular operation in all patients, including 
those who were not candidates for myocardial revas- 
cularization. They concluded that vascular surgery 
without preoperative cardiac atheterization a d cor- 
onary revascularization should produce the best clin- 
ical results because of the additional morbidity risk of 
the cardiac procedures. Our observations provide 
independent primary data that confirm this prior 
s tudy .  
Even if preliminary aortocoronary b pass urgery 
did not yield any improvement in the perioperative 
survival rate, it might still be a worthwhile consider- 
ation if it produced an increase in the long-term 
survival rate. Convincing evidence is lacldng in the 
absence of a prospective randomized study. How- 
ever, both the CASS registry12and the Duke coro- 
nary bypass urgery study 13 found that the presence 
of vascular disease was an independent predictor of 
late death after CABG, reducing the survival rate at 5 
years by about 15%. Hertzer et al.14found that pre- 
liminary myocardial revascularization in 286 periph- 
eral vascular patients out of 1000 who underwent 
routine preoperative coronary angiography reduced 
the 5-year cumulative cardiac mortality rate from 
56% to 16% when compared with a group of patients 
who had uncorrectable or inoperable CAD, a finding 
that has been used to justify preliminary myocardial 
revascularization. However, this observation is bi- 
ased in favor of the treatment group because the 
patients who had the most favorable coronary anat- 
omy were the ones selected for revascularization. I  
the present study, patients who underwent extended 
cardiac evaluation and treatment had a longer inter- 
JOURNAL OF VASCULAR SURGERY 
Volume 25, Number 6 Massie et al. 981 
val before their first MI (Fig. 1) but had no demon- 
strated improvement in the number of fatal and non- 
fatal cardiac events (Table IV) or in overall survival 
rate (Fig. 3) compared with the control group. 
One of the benefits of performing preoperative 
cardiac catheterization is the potential to identify 
patents who have coronary lesions that are treatable 
by coronary angioplasty, which may help to avoid the 
morbidity and time delay that is associated with 
CABG. Interestingly, only one of the 70 patients 
who underwent coronary angiography in this study 
had CAD suitable for PTCA. The limited utility of 
coronary angioplasty in peripheral vascular surgery 
patients has been noted by others. Bry et al)s and 
McEnroe et al. 16 each reported that PTCA was pos- 
sible in only 6% of vascular surgical patients who had 
undergone cardiac catheterization. Coronary angio- 
plasty is best suited to treat one or two isolated, 
hemodynamically important coronary stenoses, 
which are rarely found in patients who have symp- 
tomatic peripheral vascular disease. In the present 
study, many patients were found to have multiple 
stenoses and were therefore better suited to CABG 
(34%). In most of the remaining patients in the 
present study, revascularization would not have im- 
proved cardiac risk (56%) or the disease was so diffuse 
that no means ofrevascularization was possible (7%). 
These findings uggest that performing coronary an- 
giography with the hope of finding a coronary steno- 
sis that can be treated with a limited procedure such 
as angioplasty or atherectomy is probably unjustified. 
The most important limitation of this study is the 
absence of randomization between the catheteriza- 
tion and control groups. The validity of the conclu- 
sions rely on the probability that a dozen or more 
cardiologists with a range of evaluation philosophies 
would recommend coronary angiography or no an- 
giography more or less randomly. Any treatment bias 
would probably favor more aggressive treatment for 
chronic stable angina, which, in fact, was observed in 
the catheterization group (p = 0.049). Despite the 
increased incidence of symptoms in the treatment 
group, there was no difference in perioperative car- 
diac events or long-term survival rate when com- 
pared with patients who did not undergo extended 
cardiac evaluation. Recent studies have indicated that 
as many as 90% of patients have no chest pain with 
myocardial ischemia, 17,18 as determined by ST seg- 
ment depression on ambulatory monitoring. It is 
therefore quite possible that the severity of the un- 
derlying CAD is similar in both groups, but cardiol- 
ogists were more apt to recommend cardiac atheter- 
ization for patients with a history of chest pain. 
Coronary angiography and myocardial revascu- 
larization in patients with symptomatic peripheral 
vascular disease has been associated with morbidity 
and mortality rates substantially higher than in pa- 
tients with symptomatic CAD alone. Indeed, in this 
study, three patients died after either coronary an- 
giography or CABG before they could undergo the 
planned vascular procedure. Our data lead to the 
conclusion that the risks of extended cardiac evalua- 
tion and treatment did not produce any improve- 
ment in either perioperative or long-term survival 
rates. The added morbidity risk associated with cor- 
onary angiography and myocardial revascularization 
as well as the requisite delay in treatment of the 
vascular diagnosis are not justified for patients who 
have asymptomatic or stable CAD. For most patients 
who have a positive result of a DT scan, coronary 
angiography did not provide any useful additional 
information. Coronary angiography and myocardial 
revascularization should be reserved for those few 
patients who have unstable angina or significant isch- 
emic ventricular dysfunction. Although our study 
showed that coronary angiography and myocardial 
revascularization procedures did not result in in- 
creased survival rates, it is possible that symptoms 
were reduced and the overall quality of life was im- 
proved. Further study of this issue, including the 
cost-effectiveness of various treatment options and 
functional outcomes, is clearly warranted. 
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ciate Professor of Biostatistics and Epidemiology, School 
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D ISCUSSION 
Dr. Robert  A. Scarpato (Hyannis, Mass.). My ques- 
tion is, why should a surgeon order a DT scan? I tend to 
have all of the patients who are scheduled for aortic surgery 
undergo a DT scan screening or at least see a cardiologist, 
and that amounts to the same thing, I guess. But what you 
are saying is that it does not really affect the outcome, so 
could you step back one step and justify why we should 
even do that? What valuable information do we get? 
Dr. Mitchell  T. Massie. Our study did not evaluate 
the potential value of performing routine DT scans before 
peripheral vascular operations. However, we did find that 
the results of the scan did influence subsequent manage- 
ment in the group of 70 patients who underwent coronary 
angiography. On the basis of the results of the DT scan, 
86% of these patients had changes in the management of
cardiac or peripheral vascular disease, or both. 
Dr. John A. Mannick (Boston, Mass.). Can you tell 
me how many of the cardiac deaths occurred after the 
patient underwent a myocardial revascularization proce- 
dure in this series? 
Dr. Massie. There were two deaths in the 24 patients 
who underwent coronary artery bypass grafting proce- 
dures. 
Dr. Mannick.  I am very interested in this outcome, 
and I think that you were unlucky to have those two deaths 
in this series, but I think it proves a point that I have been 
worried about for some years. As you probably know, our 
philosophy about operating on people's aortas has been 
similar to the philosophy that you have used in Worcester. 
We would simply operate on patients who had no evidence 
of coronary disease without performing further studies. We 
did a work-up on those patients who had some clinical 
evidence of coronary disease and then operated on some of 
them prophylactically before performing the aortic surgical 
procedure. In our study, this was a small group. We had no 
deaths after coronary revascularization procedures, o the 
figures look very good, but one death in that group would 
have changed the figures to look as though we had done 
nothing at all for our patients, and I think what you have 
reported is a caution that perhaps ophisticated work-up of 
these individuals may have very little to offer when one 
really analyzes the situation. 
Dr. David C. Brewster (Boston, Mass.). I am very 
impressed that a group such as yours, with long experience 
and with interest in DT scanning and previously an advo- 
cate of such studies, now seems to have analyzed current 
experience and come to an opposite conclusion. The lure 
in many cases is that an easy fix might be available by 
PTCA, but I think an important message that you have 
given us is that this is often not possible. In addition, your 
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data underscore that myocardial revascularization does not 
come free, and I think it is essential that we do not over- 
look this fact. 
I have a few brief questions for you. Did you analyze 
whether the number of zones of redistribution, if you were 
able to quantify that, had any effect on the outcome? In 
other words, does the extent of disease, and therefore 
presumably operative risk, correlate with the number of 
zones of redistribution and therefore influence your re- 
sponse to a positive result of a study? 
Second, although it may not affect outcome, I still 
think that in certain patients performing this sort of preop- 
erative valuation does have an important role in aiding the 
surgeon in procedure selection. For instance, in aortoiliac 
occlusive disease there are obviously many ways to treat a 
patient, and I think that lmowledge in regard to coronary 
disease and operative risk may well influence you about 
what direction to go. Therefore, I would not totally aban- 
don preoperative cardiac evaluation i all patients. 
Dr. Massie. We found a weak correlation between the 
number of segments of redistribution  DT scan and the 
number of clinically significant stenoses on coronary an- 
giography. We did not look at the size of the zones of 
redistribution. There was no clear correlation between the 
number of segments of redistribution a d cardiac ompli- 
cations. 
Dr. Anthony D. Whittemore (Boston, Mass.). I, too, 
would like to commend you on your study. Your group has 
made some terrific contributions to this field in the past 
and this is another important observation, but as is true 
with most of these studies there is a concern that I have 
with respect o your control and your study design. It 
seems to me extraordinarily difficult to filter out the effect 
of a heightened awareness of coronary disease. For in- 
stance, your at-risk group had a 49% incidence of chronic 
stable angina, which was a significant difference over and 
above your control, and they did have redistribution. How 
did that affect anesthetic management? I just wondered 
whether you would elaborate on that a little bit. Did it 
increase the incidence of [3-blockade or the use of nitro- 
glycerin or myocardial protective mechanisms that was 
different than in your control group? 
Dr. Massie. On the basis of the findings of DT scan- 
ning, 73% of patients in this study had changes in the 
medical management of their CAD. The most common 
changes were the addition of nitrates or calcium channel- 
blocking or [3-blocking agents. The information obtained 
from DT scanning was also helpful to our anesthesia and 
critical care colleagues in planning the patients' intraoper- 
ative and postoperative management. Lastly, you may be 
aware of the studies performed in San Francisco to evaluate 
compliance with universal precautions. They found that 
compliance was very good when combined with a system 
to identify high-risk patients. However, compliance was 
poor when they attempted to treat all patients as if they 
were high risk. I am concerned that if we apply the San 
Francisco approach to the preoperative assessment of car- 
diac risk in vascular patients by treating everyone as if he 
were at high risk that eventually our vigilance will relax, 
with potentially grave consequences. 
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